Big Pharma on the backfoot in India
In March, the Indian Patent Office granted Hyderabad-based Natco Pharma a "compulsory licence" to sell a generic version of German company Bayer AG's kidney and liver cancer drug, Nexavar. It was the first instance of an Indian company getting a ...
India rejects AstraZeneca patent appeal on Iressa
Natco Pharma hits record high after IPAB dismisses AstraZeneca drug appeal
Patents appeal board rejects AstraZeneca's plea on cancer drug